PubRank

H Rochant

Author PubWeight™ 55.75‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. French Society of Haematology. Lancet 1996 2.41
2 Evolution of bacterial susceptibility to antibiotics during a six-year period in a haematology unit. J Hosp Infect 1995 1.39
3 Myeloid and megakaryocytic properties of K-562 cell lines. Cancer Res 1983 1.23
4 Hepatic vein thrombosis in paroxysmal nocturnal hemoglobinuria. A spectrum from asymptomatic occlusion of hepatic venules to fatal Budd-Chiari syndrome. Gastroenterology 1987 1.18
5 Anomalies of blood group antigens and erythrocyte enzymes in two types of chronic refractory anaemia. Br J Haematol 1969 1.08
6 [Refractory anemias: acquired enzymopathies of hematopoietic stem cells]. Nouv Rev Fr Hematol 1969 1.08
7 Regulation of transferrin receptors in human hematopoietic cell lines. J Biol Chem 1984 1.06
8 T-cell lymphoma revealed by a peripheral neuropathy. A report of two cases with an immunohistologic study on lymph node and nerve biopsies. Cancer 1986 1.05
9 [Characteristics of autoimmune hemolytic anemia in adults: retrospective analysis of 83 cases]. Rev Med Interne 2002 1.04
10 Graft versus host reaction and lichen planus. Br J Dermatol 1975 1.01
11 Carbonic anhydrase I is an early specific marker of normal human erythroid differentiation. Blood 1985 0.98
12 [New immunologic classification of the hemolytic anemias with autoantibodies]. Nouv Rev Fr Hematol 1968 0.97
13 Hemin regulates the expression of transferrin receptors in human hematopoietic cell lines. FEBS Lett 1982 0.96
14 The role of iron in the growth of human leukemic cell lines. J Cell Physiol 1984 0.96
15 Transferrin binding to K562 cell line. Effect of heme and sodium butyrate induction. Exp Cell Res 1982 0.92
16 Usefulness of consensus conferences: the case of albumin. Lancet 1992 0.89
17 [Diffuse interstitial fibrosis of the lung in Hodgkin's disease treated by high doses of endoxan]. Bull Mem Soc Med Hop Paris 1968 0.88
18 Lambda cold agglutinin with anti-A 1 specificity in a patient with reticulosarcoma. Vox Sang 1972 0.87
19 Erythroid properties of K562 cells. Effect of hemin, butyrate and TPA induction. Exp Cell Res 1983 0.86
20 Impact of magnetic resonance imaging on the diagnosis of abdominal complications of paroxysmal nocturnal hemoglobinuria. Blood 1995 0.86
21 The iron-chelating agent picolinic acid enhances transferrin receptors expression in human erythroleukaemic cell lines. Br J Haematol 1985 0.86
22 Increase-platelet-associated IgG in patient on high-dose gammaglobulin for autoimmune thrombocytopenic purpura. Lancet 1982 0.86
23 Genetic regulation of gamma gene expression: study of the interaction of beta-thalassemia with heterocellular HPFH. Hum Genet 1981 0.85
24 Abnormally expanded CD8+/Leu-7+ lymphocytes persisting in long-term bone marrow-transplanted patients are resting pre-cytotoxic T-lymphocytes. Exp Hematol 1990 0.85
25 [Refractory anemia with excess myeloblasts in the bone marrow. Study of 11 cases]. Presse Med 1970 0.85
26 Quinine improves the results of intensive chemotherapy in myelodysplastic syndromes expressing P glycoprotein: results of a randomized study. Br J Haematol 1998 0.84
27 Presence of the Tn antigen on hematopoietic progenitors from patients with the Tn syndrome. J Clin Invest 1985 0.84
28 Splenic rupture due to aspergillosis. Nouv Rev Fr Hematol 1983 0.83
29 [Developmental aspects of angioimmunoblastic lymphadenopathy. Apropos of 3 cases]. Ann Med Interne (Paris) 1976 0.83
30 In vitro inhibition of normal human hematopoiesis by marrow CD3+, CD8+, HLA-DR+, HNK1+ lymphocytes. Blood 1988 0.82
31 Defect in glycosylation of erythrocyte membrane proteins in congenital dyserythropoietic anaemia type II (HEMPAS). Br J Haematol 1984 0.82
32 Clonal expression of the Tn antigen in erythroid and granulocyte colonies and its application to determination of the clonality of the human megakaryocyte colony assay. J Clin Invest 1982 0.82
33 Adult patients presenting with pancytopenia: a reappraisal of underlying pathology and diagnostic procedures in 213 cases. Hematol Pathol 1989 0.82
34 [The auto-antibodies of acquired hemolytic anemias. II. Nature, specificity, clinical interest and mechanism of formation]. Nouv Rev Fr Hematol 1968 0.81
35 Efficiency of prophylactic granulocyte transfusions in preventing infections in acute leukaemia. Rev Fr Transfus Immunohematol 1979 0.80
36 Frequent detection of minimal residual disease by use of the polymerase chain reaction in long-term survivors after bone marrow transplantation for chronic myeloid leukemia. Leukemia 1990 0.80
37 Exhaustive analysis of the P53 gene coding sequence by denaturing gradient gel electrophoresis: application to the detection of point mutations in acute leukemias. Hum Mutat 1994 0.80
38 Induction of cytolytic function in resting peripheral blood CD8+/Leu-7+ T cells through IL2/p 75 IL2-receptor interaction: a study in the allogeneic human bone marrow transplantation model. Cell Immunol 1990 0.80
39 [Refractory anaemia with an excess of myeloblasts and cutaneous vasculitis (author's transl)]. Nouv Rev Fr Hematol 1981 0.80
40 Danazol in autoimmune haemolytic anaemia. Br J Haematol 1993 0.80
41 Regulation of i- and I-antigen expression in the K562 cell line. Cancer Res 1982 0.80
42 Electrophoretic and kinetic studies of human erythrocytes deficient in pyrimidine 5'-nucleotidase. Hum Genet 1977 0.79
43 [Autoantibodies in acquired hemolytic anemia. I. Analysis of 234 cases]. Nouv Rev Fr Hematol 1968 0.79
44 A prospective study of autologous bone marrow or peripheral blood stem cell transplantation after intensive chemotherapy in myelodysplastic syndromes. Groupe Français des Myélodysplasies. Group Ouest-Est d'étude des Leucémies aiguës myéloïdes. Leukemia 1999 0.79
45 [A new case of congenital dyserythropoiesis type II. Immunological characteristics and hereditary transmission of the polyagglutinable antigen distinct of T, Tn and Cad antigens (author's transl)]. Nouv Rev Fr Hematol 1975 0.79
46 Central nervous system relapses after bone marrow transplantation for acute lymphoblastic leukemia in remission. Cancer 1989 0.78
47 Quinine improves results of intensive chemotherapy (IC) in myelodysplastic syndromes (MDS) expressing P-glycoprotein (PGP). Updated results of a randomized study. Groupe Français des Myélodysplasies (GFM) and Groupe GOELAMS. Adv Exp Med Biol 1999 0.78
48 Effect of phorbol esters on iron uptake in human hematopoietic cell lines. Cancer Res 1984 0.78
49 Expression of the blood group I, i, H, and A1 antigens on erythrocyte membranes studied by immunofluorescence. J Clin Lab Immunol 1980 0.78
50 Pulmonary fibrosis subsequent to high doses of CCNU for chronic myeloid leukemia. Cancer 1983 0.78
51 Reticulocytosis, hypochromia, and microcytosis: an unusual presentation of the preleukemic syndrome. Blood 1982 0.77
52 Disappearance of Hb F and i antigen during the first year of life. Am J Hematol 1980 0.77
53 Immunophenotype of leukemic blasts with small peroxidase-positive granules detected by electron microscopy. Leukemia 1988 0.77
54 Making choices in hospital resources allocation. The use of an assessment tool to decide which new projects are financed. Int J Technol Assess Health Care 1996 0.77
55 Cytomegalovirus encephalitis occurring after bone marrow transplantation. Scand J Haematol 1983 0.77
56 Elevated Hb F associated with beta-thalassaemia trait: haemoglobin synthesis in reticulocytes and in blood BFU-E. Scand J Haematol 1980 0.77
57 Expression of SSEA-I antigen (3-fucosyl-N-acetyl-lactosamine) on normal and leukaemic human haemopoietic cells: modulation by neuraminidase treatment. Br J Haematol 1984 0.77
58 In vitro inhibition of hematopoiesis by HNK1, DR-positive T cells and monocytes after allogeneic bone marrow transplantation. Exp Hematol 1987 0.76
59 Ultrastructural and cytochemical characterization of blasts from early erythroblastic leukemias. Leukemia 1987 0.76
60 Inhibition of transferring binding and iron uptake of hematopoietic cell lines by phorbol esters. Leuk Res 1984 0.76
61 Change in i-antigen expression of erythrocytes during in vivo aging. Rev Fr Transfus Immunohematol 1981 0.76
62 Congenital dyserythropoietic anemia type III. studies on erythroid differentiation of blood erythroid progenitor cells (BFUE) in vitro. Exp Hematol 1980 0.76
63 [Bone marrow necrosis disclosing multiple myeloma of bone]. Presse Med 1985 0.75
64 [Thrombocytopenic thrombotic purpura in adults. 10 cases (author's transl)]. Nouv Presse Med 1980 0.75
65 HLA-DR restriction in suppression of hematopoiesis by T cells from allogeneic bone marrow transplants. J Immunol 1986 0.75
66 [Comments about use of polychemotherapy MOPP associated with radiotherapy in the treatment of early stages of Hodgkin's disease. Preliminary report of 58 patients (author's transl)]. Ann Med Interne (Paris) 1980 0.75
67 Fetal hemoglobin synthesis in culture of early erythroid precursors (BFU-E) from the blood of normal adults. J Cell Physiol 1980 0.75
68 Congenital sideroblastic anemia without clinical iron overload. A case report. Nouv Rev Fr Hematol 1990 0.75
69 [Severe hematologic complications of gold salts prescribed in excessive doses. Apropos of 2 cases]. Therapie 1985 0.75
70 Early response to chemotherapy as a prognostic factor in Hodgkin's disease. Cancer 1983 0.75
71 [Lymphoid leukemia: recent progress]. Bull Mem Soc Med Hop Paris 1967 0.75
72 [Studies of modifications of blood group antigens in 11 cases of "refractory anemia"]. Nouv Rev Fr Hematol 1969 0.75
73 [Acute leukemia and breast cancer : apropos of 12 cases observed in the Department of Oncology at the Henri Mondor Hospital]. Bull Cancer 1983 0.75
74 Biological abnormalities in erythroblasts and erythrocytes of acquired idiopathic dyserythropoietic anemia. Haematologica 1974 0.75
75 [Multiple myeloma with high tumoral mass. Treatment combining melphalan, cyclophosphamide, vincristine, CCNU and prednisone. 35 cases]. Presse Med 1983 0.75
76 Adult T-cell lymphoma leukemia in Western countries. Am J Hematol 1983 0.75
77 [Elements of prognosis in common cirrhosis. Contributions of immunological data and multidimentional statistical methods]. Rev Med Chir Mal Foie 1971 0.75
78 [Treatment of acute myeloblastic leukemia. 79 cases treated by cytosine-rubidomycin combination]. Nouv Presse Med 1974 0.75
79 [Cellular regulation of the expression of i and I antigens during the in vitro differentiation of BFU-E]. C R Seances Acad Sci D 1980 0.75
80 The treatment of chronic myelogenous leukemia by interferon and cytosine-arabinoside: rational and design of the French trials. French CML Study Group. Bone Marrow Transplant 1996 0.75
81 [Refractive anemia, preleukemic states and multiple enzymatic anomalies]. C R Acad Sci Hebd Seances Acad Sci D 1968 0.75
82 Cost of allogeneic bone marrow transplantation in four diseases. Health Policy 1989 0.75
83 [An atypical form of Waldenstrom's macroglobulinaemia with complete remission lasting for more than two years after multiple chemotherapy (author's transl)]. Ann Med Interne (Paris) 1979 0.75
84 [Alveolar proteinosis associated with chronic myelocytic leukemia]. Presse Med 1984 0.75
85 Enhancement of alloimmunization: a potential hazard of GM-CSF treatment in patients with severe aplastic anemia? Transfusion 1989 0.75
86 [Bone marrow grafts and acute leukemia]. Acquis Med Recent 1981 0.75
87 [Hemochromatotic cirrhosis complicating pyridoxine-sensitive hereditary sideroblastic anemia. Case report]. Ann Med Interne (Paris) 1983 0.75
88 A case of sickle cell anemia with severe infection, transfusion inefficiency and transient sideroblastic anemia. Nouv Rev Fr Hematol 1988 0.75
89 [Thrombosis of the smaller hepatic veins. Diagnostic value of retrograde hepatic phlebography]. J Radiol Electrol Med Nucl 1973 0.75
90 [Managing of an innovation in health care: the case of polyvalent intravenous immunoglobulins at the Assistance-Publique-Hôpitaux de Paris]. Ann Med Interne (Paris) 1995 0.75
91 F-cells are preferentially distributed among high density erythrocytes. Biomedicine 1981 0.75
92 [Normal erythropoiesis and its regulation]. Ann Biol Clin (Paris) 1967 0.75
93 [Mixed lympho-epidermal cell cultures: value in bone marrow grafts]. Presse Med 1989 0.75
94 Cellular regulation of i and I antigen expressions in human erythroblasts grown in vitro. Stem Cells 1981 0.75
95 [Analysis of the conditions of antibody appearance in hepatic cirrhosis]. Nouv Rev Fr Hematol 1968 0.75
96 [Immunoglobulin anomalies and monoclonal peaks after allogeneic bone marrow transplantation]. Nouv Presse Med 1980 0.75
97 [Hyponatremia in acute leukemia]. Ann Med Interne (Paris) 1978 0.75
98 [Physiopathology of iron absorption]. Nouv Rev Fr Hematol 1967 0.75
99 [On attack treatment using rubidomycin in 19 cases of acute myeloblastic leukemia]. Presse Med 1968 0.75
100 Abnormal distribution of erythrocytes A1 antigens in preleukemia as demonstrated by an immunofluorescence technique. Nouv Rev Fr Hematol Blood Cells 1976 0.75
101 [Modulation of the expression of transferrin receptors by iron, hemin and protoporphyrin IX]. C R Seances Acad Sci III 1983 0.75
102 [Changes in acid-base balance during nalidixic acid infusion in 23 patients (author's transl)]. Therapie 1982 0.75
103 Mixed epidermal cell-lymphocyte reaction in prediction of acute graft-versus-host disease in bone marrow recipients. J Natl Cancer Inst 1986 0.75
104 A multicentre study of a randomized therapeutic protocol in previously untreated patients with Ph-positive chronic myelogenous leukaemia: interferon alfa-2b and hydroxyurea with or without cytosine arabinoside , preliminary results. Eur J Cancer 1991 0.75
105 [Lactic acidosis during acute leukemia]. Ann Med Interne (Paris) 1975 0.75
106 [Modifications of the allotypic expression of immunoglobulins during some hemopathies]. Nouv Rev Fr Hematol 1970 0.75
107 [Immunological study of cirrhotic disease. Statistical analysis of 106 cases]. Rev Med Chir Mal Foie 1971 0.75
108 The number of the Trf receptors on human hematopoietic cell lines is influenced by membrane phospholipids. Biochem Int 1983 0.75
109 [Autoantibody-induced hemolytic anemia in chronic lymphocytic leukemia]. Nouv Rev Fr Hematol 1982 0.75
110 [Chemotherapy-radiotherapy association in the treatment of localized forms of Hodgkin's disease. Prognosis of polychemotherapy after three trials of M.O.P.P]. Nouv Rev Fr Hematol Blood Cells 1977 0.75
111 [Hemolytic anemias with a negative Coombs' test and a positive Coombs' test without hemolytic anemia]. Ann Med Interne (Paris) 1980 0.75
112 [Chronic anemia: diagnostic tools and approach]. Rev Prat 1993 0.75
113 Characterization of phorbol esters binding to K 562 cells. Anticancer Res 1984 0.75
114 [Letter: Treatment of infections in acute leukemia with therapeutic aplasia. Efficacy of the antibiotic combinations gentamicin-carbenicillin or colistin-carbenicillin after failure of other combinations]. Nouv Presse Med 1975 0.75
115 Successful allogeneic bone marrow transplantation after reversion of chronic phase of blast crisis in chronic myeloid leukemia. Am J Hematol 1981 0.75
116 [Polyagglutinability due to Hempas antigen]. Rev Fr Transfus Immunohematol 1976 0.75
117 [Modification of the blood group of transfused erythrocytes in a patient presenting an acquired B antigen]. Nouv Presse Med 1972 0.75
118 [Quantitative assay of RBC antigens I and i in pathology (author's transl)]. Nouv Rev Fr Hematol 1973 0.75
119 [Post-hepatitic aplasia treated by grafts of allogenic bone marrow. Remission for more than 2 years. Persistance of a total hematopoietic chimera. Graft versus host reaction]. Nouv Presse Med 1975 0.75
120 Expression of blood group A antigen during erythroid differentiation in A1 and A2 subjects. Leukemia 1987 0.75
121 [Clinical implications of the new immunologic classification of the hemolytic anemias with autoantibodies]. Nouv Rev Fr Hematol 1968 0.75
122 [Bacterial septicemia in neutropenia patients]. Ann Med Interne (Paris) 1983 0.75
123 [Resuscitation of acute leukemia patients]. Rev Prat 1976 0.75
124 [Acute monoblastic leukemia. Clinical and therapeutic aspects in 20 cases]. Ann Med Interne (Paris) 1976 0.75
125 Treatment of adult acute lymphoblastic leukemia. Preliminary results of a trial from the French Group. Haematol Blood Transfus 1987 0.75
126 Comparative patterns of i-antigen expression, F-cell frequency and Hb A2 level in acute myeloid leukemia and in acute lymphoid leukemia. Leuk Res 1981 0.75
127 High dose intravenous gammaglobulin and platelet transfusions in leukaemic HLA-immunized patients. Scand J Haematol 1984 0.75
128 Acute non myeloid leukaemia in adults. Prognostic factors in 92 patients. Scand J Haematol 1980 0.75
129 [Calculation of direct standard costs in the evaluation of new technologies: application to the treatment of acute myeloblastic leukemias]. Rev Epidemiol Sante Publique 1986 0.75
130 [3 cases of "acquired B" erythrocyte phenotype. The pseudo-B specificity appears to be acquired at the expense of the A specificity]. Rev Fr Transfus 1974 0.75
131 A new case of monoclonal IgA kappa cold agglutinin with anti-Pr1d specificity in a patient with persistent HB antigen cirrhosis. Vox Sang 1976 0.75
132 A multicentric randomised study of alpha 2b interferon (IFN) and hydroxyurea (HU) with or without cytosine-arabinoside (Ara-c) in previously untreated patients with Ph+ chronic myelocytic leukemia (CML): preliminary cytogenetic results. Leuk Lymphoma 1993 0.75
133 [Hemorrhagic syndrome caused by acquired Stuart-Prower factor deficiency. Amyloidosis. Waldenstrom's disease]. Bull Mem Soc Med Hop Paris 1966 0.75
134 [Immunologic study of cirrhotic disease. Statistical analysis of 106 cases]. Rev Eur Etud Clin Biol 1970 0.75
135 [Antineoplastic chemotherapy in 1980. Current status and prospects]. Rev Prat 1980 0.75